Studying How Gut Fermentation Affects Obesity and Insulin Resistance in Young People
Tests lactulose in young people with obesity to study gut fermentation and insulin resistance.
Key facts
- Who runs it
- Yale University
- Where
- New Haven, United StatesSee the site
- Trial code
- Registry title
- New Mechanisms of Obesity
- Status
- Recruiting
- People taking part
- 55 people, planned
- Started
- 13 Nov 2025
- Expected to end
- 31 Mar 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Lactulose Oral Product
- Record updated
- 28 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people aged 15 to 22 who have obesity and are in puberty. It studies how gut fermentation and insulin resistance affect metabolism.
- Age
- 15 to 22 years
- Sex
- All sexes can join.
- Disease stage
- In puberty (Tanner stage III-V) and a BMI above the 85th percentile.
- Earlier treatment
- Cannot be taking medicines that affect insulin resistance, such as metformin or GLP-1 analogues.
Main reasons for not taking part
- Pregnancy
- Hormone gland diseases (e.g., Cushing syndrome)
- Substance abuse
- Medicines affecting insulin resistance, such as metformin or GLP-1 analogues
- High fibre intake (more than 30g/day) on a 3-day food record
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age 15 to 22 years
- In puberty (girls and boys: Tanner stage III-V)
- BMI >85th
Who cannot take part
- medications affecting insulin resistance such as metformin, GLP-1 analogues; -
- endocrinopathies (e.g., Cushing syndrome)
- Pregnancy
- substance abuse
- high fibers intake (> 30g/day) as assessed by a 3-day food record
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 15 and 22 years old?
Where in United States
- Yale UniversityNew Haven, United StatesContact: NICOLA SANTORO, MD, PhDTaking people
About the trial
What the trial wants to find out
Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in youth with obesity.
The 2 groups in the trial
- Remote physical exerciseTreatment being tested
Treatment: Lactulose Oral Product
- Control physical exerciseExisting treatment, for comparison
Treatment: Lactulose Oral Product
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications
- Plain-language title
- Studying How Gut Fermentation Affects Obesity and Insulin Resistance in Young PeopleGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06768827, who can take part
- Record updated
- 28 January 2026